Immunization is a cornerstone of public health policy and is demonstrably highly cost-
effective when used to protect child health. Although it could be argued that immunology has …

Antimicrobial resistance (AMR) is emerging as the next potential pandemic. Different
microorganisms, including the bacteria Acinetobacter baumannii, Clostridioides difficile …

ABSTRACT Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed
the global importance of meningococcal disease (MD) and its continually changing …

Background Neisseria meningitidis is an important cause of meningitis and septicaemia, but
most infected individuals experience a period of asymptomatic carriage rather than disease …

Background The meningococcal group B vaccine 4CMenB is a new, recombinant protein-
based vaccine that is licensed to protect against invasive group B meningococcal disease …

Background Meningococcal conjugate vaccines protect individuals directly, but can also
confer herd protection by interrupting carriage transmission. We assessed the effects of …

Background An effective, affordable, multivalent meningococcal conjugate vaccine is
needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and …

Background. Herd protection by meningococcal vaccines is conferred by population-level
reduction of meningococcal nasopharyngeal colonization. Given the inverse …

Background An affordable, highly immunogenic Neisseria meningitidis serogroup A
meningococcal conjugate vaccine (PsA–TT) was licensed for use in sub-Saharan Africa in …

Vaccination and herd immunity: what more do we know? : Current Opinion in Infectious
Diseases Vaccination and herd immunity: what more do we know? : Current Opinion in …